| 1 |
35062050 | CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. | 2022 Feb |
2 |
| 2 |
27713827 | Evaluation of a novel PXR-knockout in HepaRG™ cells. | 2016 Oct |
1 |
| 3 |
26516577 | Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies. | 2015 Oct |
1 |
| 4 |
19855097 | CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose. | 2010 Feb |
1 |
| 5 |
18606396 | Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. | 2009 Feb 15 |
1 |
| 6 |
18332078 | Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. | 2008 Jun |
1 |
| 7 |
15849716 | Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. | 2005 |
1 |
| 8 |
12695351 | Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. | 2003 May |
1 |
| 9 |
12065438 | CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. | 2002 Jul |
1 |